Deep search
Web
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pharmacy benefit managers inflated drug prices by $7.3B
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts
US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S.
FTC releases second report slamming pharmacy benefit managers
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the controversial drug middlemen as the agency’s first report released last summer — but relies on more data.
5h
on MSN
Several Setbacks Dragged CVS Health Corp. (CVS) in Q4
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...
6h
What's Going On With CVS Health Stock?
CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...
Hosted on MSN
2d
What You Need To Know Ahead of CVS Health's Earnings Release
With a market cap of $64.8 billion, CVS Health Corporation (CVS) is a leading pharmacy innovation company providing a wide ...
7d
After Falling More Than 40% in 2024, Can CVS Health Stock Turn Things Around This Year?
CVS Health ( CVS 4.35%) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in ...
11h
Wedmont Private Capital Reduces Position in CVS Health Co. (NYSE:CVS)
Wedmont Private Capital lessened its holdings in shares of CVS Health Co. (NYSE:CVS – Free Report) by 21.5% in the fourth ...
1d
Bernstein Sticks to Their Hold Rating for CVS Health (CVS)
Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The ...
1d
CVS Health: Current Price Offers Favorable Risk-Reward Profile
CVS Health Corporation is a vertically integrated healthcare corporation in the United States. The company owns a leading ...
12h
Claro Advisors LLC Decreases Stake in CVS Health Co. (NYSE:CVS)
Claro Advisors LLC trimmed its position in shares of CVS Health Co. (NYSE:CVS – Free Report) by 59.7% during the fourth ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback